Ergoteles LLC Cytosorbents Corp Transaction History

Ergoteles LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$1.79 - $4.17 $137,885 - $321,219	-77,031 Reduced 79.24%	20,185 $68,000
Q4 2022 Feb 14, 2023	SELL	$1.03 - $2.03 $82,695 - $162,982	-80,287 Reduced 45.23%	97,216 $150,000
Q3 2022 Nov 14, 2022	SELL	$1.2 - $2.46 $30,236 - $61,984	-25,197 Reduced 12.43%	177,503 $241,000
Q2 2022 Aug 12, 2022	BUY	$1.76 - $3.22 $356,752 - $652,694	202,700 New	202,700 $444,000

16.7M

15.4K

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $42.3M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.